鉄：鉄欠乏性脱毛症

Q: Does 鉄 help with 鉄欠乏性脱毛症?

Based on 73 studies with 30,034 participants, there is strong evidence from multiple clinical trials that 鉄 may support 鉄欠乏性脱毛症 management. Our evidence grade is A (Strong Evidence).

Q: How much 鉄 should I take for 鉄欠乏性脱毛症?

Studies have used various dosages. A commonly studied range is 18 mg/day (women). Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of 鉄?

Reported side effects may include Constipation (most common), Nausea and stomach cramps, Dark or black stools, Iron overload with excessive supplementation (hemochromatosis risk). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for 鉄 and 鉄欠乏性脱毛症?

We rate the evidence as Grade A (Strong Evidence). This rating is based on 73 peer-reviewed studies with 30,034 total participants. The overall direction of effect is mixed.

A エビデンス複数の大規模臨床試験が一貫して有意な効果を示しています。

合計30,034名の参加者を対象とした73件の研究（メタアナリシス4件を含む）に基づく。研究間で結果にばらつきが見られる。

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Diron\u0026condition\u003Diron\u002Ddeficiency\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

結論

Iron deficiency is clearly linked to hair loss, and correcting a genuine deficiency may support hair regrowth, but iron supplementation is not universally effective for all types of hair loss.

73 studies across 30,034 participants provide extensive evidence on the iron-hair loss connection
Low serum ferritin levels are frequently observed in patients with hair loss
Supplementation appears most beneficial when a true iron deficiency is documented
Iron supplementation without confirmed deficiency may not improve hair outcomes and can carry risks

Key Study Findings

review

[Restless leg syndrome. Diagnosis and treatment].

Dose: various vs: Placebo 効果: None None

case-control n=90

Restless Leg Syndrome and Association with Serum NT Pro-CNP.

Dose: None vs: Placebo 効果: NT pro-CNP significantly lower in RLS vs controls; sensitivity 80%, specificity 88.9%; serum iron lo None

cross-sectional study n=100

Assessment of Serum Ferritin Levels in Female Patients With Telogen Effluvium.

Dose: not applicable (observational; serum ferritin measured) vs: Placebo 効果: mean ferritin 24.30 vs 44.78 ng/mL < 0.001

cross-sectional n=150

Prevalence of Restless Leg Syndrome and Its Association With Iron Deficiency in Patients With Chronic …

Dose: None vs: Placebo 効果: RLS prevalence 42%; serum ferritin lower in RLS (88.4 vs 126.7 ng/mL); TSAT lower (16.3% vs 22.1%); p < 0.01

retrospective observational n=113

Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases.

Dose: None vs: Placebo 効果: None None

review

Optimizing Restless Legs Syndrome Care: Integrating Rehabilitation into Multimodal Management.

Dose: None vs: Placebo 効果: None None

Key Statistics

研究数

30034

参加者数

↔

Mixed

グレード

Referenced Papers

[Restless leg syndrome. Diagnosis and treatment]. Review

Revista de neurologia None 8 件の引用

Restless Leg Syndrome and Association with Serum NT Pro-CNP. Other

Neurology India 2026

Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience. Other

Journal of cosmetic … 2025 4 件の引用

Iron Metabolism and the Role of Iron Therapy in Pediatric Restless Leg Syndrome. Review

Sleep medicine clinics 2025 2 件の引用

Assessment of Serum Ferritin Levels in Female Patients With Telogen Effluvium. Other

Cureus 2025

Optimizing Restless Legs Syndrome Care: Integrating Rehabilitation into Multimodal Management. Review

JPMA. The Journal … 2025

Prevalence of Restless Leg Syndrome and Its Association With Iron Deficiency in Patients With Chronic Kidney Disease: A Cross-Sectional Observational … Other

Cureus 2025

Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases. Other

International journal of … 2025

Restless Leg Syndrome and Pregnancy. Review

Southern medical journal 2025

A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, vitamin B12, vitamin D, thyroid … Other

Journal of cosmetic … 2024 7 件の引用

Iron Deficiency and Restless Sleep/Wake Behaviors in Neurodevelopmental Disorders and Mental Health Conditions. Other

Nutrients 2024 7 件の引用

Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case … Other

Archives of dermatological … 2024 5 件の引用

Iron Supplementation May Improve the Patient's Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life Observational Study. Other

Indian journal of … 2024 4 件の引用

Brain Iron Dysregulation in Iron Deficiency Anemia-Related Restless Leg Syndrome Revealed by Neuron-Derived Extracellular Vesicles: A Case-Control Study. Other

Annals of neurology 2024 3 件の引用

Iron deficiency-related symptoms in non-anemic whole blood donors. Other

Transfusion 2024 2 件の引用

Clinical efficacy and safety of IV ferric carboxymaltose in restless legs syndrome: A meta-analysis of 537 patients. Meta-Analysis

Sleep medicine 2024 1 件の引用

Evaluation of the relationship of digital phototrichogram findings of patients with diffuse hair loss with blood TSH, ferritin and vitamin … Other

Northern clinics of … 2024 1 件の引用

Intersecting Pathways: Treating Cocaine Withdrawal and Restless Leg Syndrome with Iron and Buproprion. Case Report

Healthcare (Basel, Switzerland) 2024

Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review. Systematic Review

Tremor and other … 2023 32 件の引用

Restless leg syndrome in patients with chronic kidney disease: a hospital-based study from Upper Egypt. Other

The International journal … 2023 14 件の引用

Etiology, management, and outcomes of pediatric telogen effluvium: A single-center study in the United States. Other

Pediatric dermatology 2023 9 件の引用

The genetic etiology of periodic limb movement in sleep. Meta-Analysis

Sleep 2023 8 件の引用

Complementary and Integrative Approaches to Sleep Disorders in Children. Review

Child and adolescent … 2023 5 件の引用

Micronutrient Deficiencies and Digital Computerized Phototrichogram Analysis in Telogen Effluvium: a Retrospective Correlation Study in a Tertiary Medical Center. Other

Dermatology practical & … 2023 4 件の引用

The incidence, complications, and treatment of iron deficiency in pregnancy. Review

European journal of … 2022 109 件の引用

Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium. Other

Journal of cosmetic … 2022 22 件の引用

Exploration of restless legs syndrome under the new concept: A review. Review

Medicine 2022 15 件の引用

Behavioral sleep medicine-The need for harmonization of clinical best practice outcome measures in children and adolescents with intellectual or developmental … Review

Frontiers in psychiatry 2022 8 件の引用

Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom? Other

Turkish journal of … 2022 8 件の引用

Evaluation of MCV/RDW Ratio and Correlations With Ferritin in Telogen Effluvium Patients. Other

Dermatology practical & … 2022 6 件の引用

Does Dexmedetomidine Improve or Worsen Restless Leg Syndrome under Sedation: A Case Report and Extensive Review. Case Report

Case reports in … 2022 3 件の引用

The Association of Serum Ferritin Levels With Non-scarring Alopecia in Women. Other

Cureus 2022 3 件の引用

Restless Leg Syndrome and Sleep Disorders in Patients with Rheumatoid Arthritis and Its Relation with Anemia Parameters. Other

Acta medica (Hradec … 2021 13 件の引用

Diagnostic and Treatment Considerations in Restless Legs Syndrome Complicated by Diabetic Neuropathy. Review

Current diabetes reports 2021 5 件の引用

The role of iron repletion in adult iron deficiency anemia and other diseases. Review

European journal of … 2020 137 件の引用

Comorbidities in alopecia areata: A systematic review and meta-analysis. Meta-Analysis

Journal of the … 2019 189 件の引用

Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies. Review

Expert review of … 2019 123 件の引用

Restless legs syndrome and iron deficiency in adults with attention-deficit/hyperactivity disorder. Other

Sleep 2019 33 件の引用

NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. Observational

Journal of cosmetic … 2019 25 件の引用

Prevalence of Nutritional Deficiencies in Hair Loss among Indian Participants: Results of a Cross-sectional Study. Other

International journal of … 2017 43 件の引用

Changes of serum trace elements level in patients with alopecia areata: A meta-analysis. Meta-Analysis

The Journal of … 2017 31 件の引用

Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers. Other

Journal of renal … 2017 26 件の引用

Vitamin and Mineral Deficiencies in Patients With Telogen Effluvium: A Retrospective Cross-Sectional Study. Other

Journal of drugs … 2016 56 件の引用

Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. Other

International journal of … 2016 28 件の引用

Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia and Thyroid Function. Other

Dermatology research and … 2016 26 件の引用

Insomnia and Restless Leg Syndrome in Patients Undergoing Chronic Hemodialysis in Rafsanjan Ali Ibn Abitaleb Hospital. Other

Nephro-urology monthly 2016 21 件の引用

Importance of donor history of restless leg syndrome and pica to asses iron deficiency. Other

Transfusion and apheresis … 2016 10 件の引用

Non-invasive method distinguishes chronic telogen effluvium from mild female pattern hair loss: clinicopathological correlation. Other

International journal of … 2016 6 件の引用

Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl. Case Report

Acta dermatovenerologica Croatica … 2016 6 件の引用

Restless Leg Syndrome/Willis-Ekbom disease in women with iron deficiency anemia. Other

Ideggyogyaszati szemle 2016 6 件の引用

Asthma as a disruption in iron homeostasis. Review

Biometals : an … 2016

Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology. Review

Sleep medicine clinics 2015 158 件の引用

A Hospital-based Study to Determine Causes of Diffuse Hair Loss in Women. Other

Journal of clinical … 2015 41 件の引用

Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease). Other

Sleep medicine 2014 58 件の引用

Disorders of heavy metals. Review

Handbook of clinical … 2014 52 件の引用

Restless leg syndrome: a neglected diagnosis. Review

Nephro-urology monthly 2014 43 件の引用

Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications. Other

Dermatologic therapy 2014 13 件の引用

New treatment options for the management of restless leg syndrome. Review

The Journal of … 2014 7 件の引用

Telogen effluvium as the first symptom of Crohn's disease in a child. Case Report

Annals of gastroenterology 2014 5 件の引用

Is TrichoScan a new diagnostic method for diffuse hair loss? Other

Turkish journal of … 2014 5 件の引用

Serum ferritin and vitamin d in female hair loss: do they play a role? Other

Skin pharmacology and … 2013 127 件の引用

The diet factor in attention-deficit/hyperactivity disorder. Review

Pediatrics 2012 205 件の引用

ADMET considerations for restless leg syndrome drug treatments. Review

Expert opinion on … 2012 6 件の引用

Iron deficiency: beyond anemia. Review

Indian journal of … 2011 75 件の引用

Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. Other

Journal of the … 2010 94 件の引用

Diffuse hair loss in an adult female: approach to diagnosis and management. Review

Indian journal of … 2009 109 件の引用

Hyperferritinemia in autoimmunity. Review

The Israel Medical … 2008 61 件の引用

Nonhematological benefits of iron. Review

American journal of … 2007 61 件の引用

The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. Review

Journal of the … 2006 255 件の引用

Medical treatment of noncicatricial alopecia. Review

Seminars in cutaneous … 2006 23 件の引用

Decreased serum ferritin is associated with alopecia in women. Other

The Journal of … 2003 222 件の引用

Iron, brain and restless legs syndrome. Other

Sleep medicine reviews 2001 48 件の引用

Management of hair loss in women. Review

Dermatologic clinics 1993 38 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:: 18 mg/day (women)
deficiency:: 65-200 mg elemental iron/day

上限量： 45 mg/day

研究で検討された用量

用量	期間	効果	N
various	--	Positive	--
None	--	Positive	90
not applicable (observational; serum ferritin measured)	--	Negative	100
None	--	Positive	150
None	--	Neutral	113
None	--	Neutral	--
iron supplementation, folate, dopamine agonists (non-pharmacological and pharmacological)	--	Positive	--
None	--	Neutral	2851

推奨摂取タイミング： On an empty stomach with vitamin C for best absorption; take 2 hours apart from calcium

Safety & Side Effects

報告されている副作用

⚠ Constipation (most common)
⚠ Nausea and stomach cramps
⚠ Dark or black stools
⚠ Iron overload with excessive supplementation (hemochromatosis risk)

既知の相互作用

● Calcium supplements and dairy (reduce iron absorption by 50-60%)
● Proton pump inhibitors (omeprazole) and H2 blockers reduce absorption
● Tetracycline and quinolone antibiotics (mutual absorption reduction)
● Levothyroxine (iron reduces thyroid hormone absorption)

耐容上限摂取量： 45 mg/day

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does 鉄 help with 鉄欠乏性脱毛症?

Based on 73 studies with 30,034 participants, there is strong evidence from multiple clinical trials that 鉄 may support 鉄欠乏性脱毛症 management. Our evidence grade is A (Strong Evidence).

How much 鉄 should I take for 鉄欠乏性脱毛症?

Studies have used various dosages. A commonly studied range is 18 mg/day (women). Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of 鉄?

Reported side effects may include Constipation (most common), Nausea and stomach cramps, Dark or black stools, Iron overload with excessive supplementation (hemochromatosis risk). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for 鉄 and 鉄欠乏性脱毛症?

We rate the evidence as Grade A (Strong Evidence). This rating is based on 73 peer-reviewed studies with 30,034 total participants. The overall direction of effect is mixed.

に関する他の成分：鉄欠乏性脱毛症

L-Lysine D

鉄他の症状・状態について

休止期脱毛症 B 産後脱毛症 D

総合評価

合計30,034名の参加者を対象とした73件の研究（メタアナリシス4件を含む）に基づく。研究間で結果にばらつきが見られる。

Evidence Strength92%

High confidence

研究の内訳

RCT (0)Meta (4)Other (69)

代替成分との比較

この症状に対する他の成分との比較をご覧ください。

に関するすべての成分を見る：鉄欠乏性脱毛症

詳しく見る

References

[1] A Culebras. Rev Neurol. [Restless leg syndrome. Diagnosis and treatment]. PubMed
[2] Reyhan Yuksek et al.. Neurol India. 2026. Restless Leg Syndrome and Association with Serum NT Pro-CNP. doi:10.4103/neuroindia.NI_673_19 PubMed
[3] Ömer Karakoyun et al.. J Cosmet Dermatol. 2025. Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience. doi:10.1111/jocd.70037 PubMed
[4] Thomas Dye et al.. Sleep Med Clin. 2025. Iron Metabolism and the Role of Iron Therapy in Pediatric Restless Leg Syndrome. doi:10.1016/j.jsmc.2025.02.005 PubMed
[5] Nishantan Thamotharan et al.. Cureus. 2025. Assessment of Serum Ferritin Levels in Female Patients With Telogen Effluvium. doi:10.7759/cureus.100249 PubMed
[6] Umer Younas et al.. J Pak Med Assoc. 2025. Optimizing Restless Legs Syndrome Care: Integrating Rehabilitation into Multimodal Management. doi:10.47391/JPMA.25-97 PubMed
[7] Parimala Elangovan et al.. Cureus. 2025. Prevalence of Restless Leg Syndrome and Its Association With Iron Deficiency in Patients With Chronic Kidney Disease: A Cross-Sectional Observational … doi:10.7759/cureus.86188 PubMed
[8] Namrata Chhabra et al.. Int J Trichology. 2025. Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases. doi:10.4103/ijt.ijt_38_22 PubMed
[9] Amy M Phillips et al.. South Med J. 2025. Restless Leg Syndrome and Pregnancy. doi:10.14423/SMJ.0000000000001823 PubMed
[10] Irem Nur Durusu Turkoglu et al.. J Cosmet Dermatol. 2024. A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, vitamin B12, vitamin D, thyroid … doi:10.1111/jocd.16512 PubMed
[11] Osman S Ipsiroglu et al.. Nutrients. 2024. Iron Deficiency and Restless Sleep/Wake Behaviors in Neurodevelopmental Disorders and Mental Health Conditions. doi:10.3390/nu16183064 PubMed
[12] Nermeen Ibrahim Bedair et al.. Arch Dermatol Res. 2024. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case … doi:10.1007/s00403-024-03004-1 PubMed
[13] Boutros Soutou et al.. Indian J Dermatol. 2024. Iron Supplementation May Improve the Patient's Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life Observational Study. doi:10.4103/ijd.ijd_744_22 PubMed
[14] Apostolos Manolopoulos et al.. Ann Neurol. 2024. Brain Iron Dysregulation in Iron Deficiency Anemia-Related Restless Leg Syndrome Revealed by Neuron-Derived Extracellular Vesicles: A Case-Control Study. doi:10.1002/ana.26941 PubMed
[15] J Karregat et al.. Transfusion. 2024. Iron deficiency-related symptoms in non-anemic whole blood donors. doi:10.1111/trf.17983 PubMed
[16] Syeda Nimra Qadri et al.. Sleep Med. 2024. Clinical efficacy and safety of IV ferric carboxymaltose in restless legs syndrome: A meta-analysis of 537 patients. doi:10.1016/j.sleep.2024.09.017 PubMed
[17] Leyla Bilik et al.. North Clin Istanb. 2024. Evaluation of the relationship of digital phototrichogram findings of patients with diffuse hair loss with blood TSH, ferritin and vitamin … doi:10.14744/nci.2023.33269 PubMed
[18] Sarah Hughes et al.. Healthcare (Basel). 2024. Intersecting Pathways: Treating Cocaine Withdrawal and Restless Leg Syndrome with Iron and Buproprion. doi:10.3390/healthcare12161570 PubMed
[19] Yasaman Safarpour et al.. Tremor Other Hyperkinet Mov (N Y). 2023. Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review. doi:10.5334/tohm.752 PubMed
[20] Sherifa Ahmed Hamed et al.. Int J Neurosci. 2023. Restless leg syndrome in patients with chronic kidney disease: a hospital-based study from Upper Egypt. doi:10.1080/00207454.2021.1910256 PubMed
[21] Vivien Chen et al.. Pediatr Dermatol. 2023. Etiology, management, and outcomes of pediatric telogen effluvium: A single-center study in the United States. doi:10.1111/pde.15154 PubMed
[22] Jacob L Edelson et al.. Sleep. 2023. The genetic etiology of periodic limb movement in sleep. doi:10.1093/sleep/zsac121 PubMed
[23] Swapna N Deshpande et al.. Child Adolesc Psychiatr Clin N Am. 2023. Complementary and Integrative Approaches to Sleep Disorders in Children. doi:10.1016/j.chc.2022.08.008 PubMed
[24] Hakan Arslan et al.. Dermatol Pract Concept. 2023. Micronutrient Deficiencies and Digital Computerized Phototrichogram Analysis in Telogen Effluvium: a Retrospective Correlation Study in a Tertiary Medical Center. doi:10.5826/dpc.1303a202 PubMed
[25] Ashley E Benson et al.. Eur J Haematol. 2022. The incidence, complications, and treatment of iron deficiency in pregnancy. doi:10.1111/ejh.13870 PubMed
[26] Ahu Yorulmaz et al.. J Cosmet Dermatol. 2022. Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium. doi:10.1111/jocd.14413 PubMed
[27] Zhao Liu et al.. Medicine (Baltimore). 2022. Exploration of restless legs syndrome under the new concept: A review. doi:10.1097/MD.0000000000032324 PubMed
[28] Rosalia Silvestri et al.. Front Psychiatry. 2022. Behavioral sleep medicine-The need for harmonization of clinical best practice outcome measures in children and adolescents with intellectual or developmental … doi:10.3389/fpsyt.2022.1003019 PubMed
[29] Ümran Öner et al.. Turk J Med Sci. 2022. Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom? doi:10.3906/sag-2106-28 PubMed
[30] Saadet İbiş et al.. Dermatol Pract Concept. 2022. Evaluation of MCV/RDW Ratio and Correlations With Ferritin in Telogen Effluvium Patients. doi:10.5826/dpc.1203a151 PubMed
[31] Sandra Iskandar et al.. Case Rep Crit Care. 2022. Does Dexmedetomidine Improve or Worsen Restless Leg Syndrome under Sedation: A Case Report and Extensive Review. doi:10.1155/2022/2447461 PubMed
[32] Muhammad Fawad Aslam et al.. Cureus. 2022. The Association of Serum Ferritin Levels With Non-scarring Alopecia in Women. doi:10.7759/cureus.32123 PubMed
[33] Salih Demir et al.. Acta Medica (Hradec Kralove). 2021. Restless Leg Syndrome and Sleep Disorders in Patients with Rheumatoid Arthritis and Its Relation with Anemia Parameters. doi:10.14712/18059694.2021.24 PubMed
[34] Anisha Garg et al.. Curr Diab Rep. 2021. Diagnostic and Treatment Considerations in Restless Legs Syndrome Complicated by Diabetic Neuropathy. doi:10.1007/s11892-021-01431-2 PubMed
[35] Benjamin Elstrott et al.. Eur J Haematol. 2020. The role of iron repletion in adult iron deficiency anemia and other diseases. doi:10.1111/ejh.13345 PubMed
[36] Solam Lee et al.. J Am Acad Dermatol. 2019. Comorbidities in alopecia areata: A systematic review and meta-analysis. doi:10.1016/j.jaad.2018.07.013 PubMed
[37] Sherifa A Hamed. Expert Rev Clin Pharmacol. 2019. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies. doi:10.1080/17512433.2019.1555468 PubMed
[38] Régis Lopez et al.. Sleep. 2019. Restless legs syndrome and iron deficiency in adults with attention-deficit/hyperactivity disorder. doi:10.1093/sleep/zsz027 PubMed
[39] Kavita Poonia et al.. J Cosmet Dermatol. 2019. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. doi:10.1111/jocd.12559 PubMed
[40] Dinesh Gowda et al.. Int J Trichology. 2017. Prevalence of Nutritional Deficiencies in Hair Loss among Indian Participants: Results of a Cross-sectional Study. doi:10.4103/ijt.ijt_48_16 PubMed
[41] Waishu Jin et al.. J Dermatol. 2017. Changes of serum trace elements level in patients with alopecia areata: A meta-analysis. doi:10.1111/1346-8138.13705 PubMed
[42] Niloufar Zadeh Saraji et al.. J Renal Inj Prev. 2017. Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers. doi:10.15171/jrip.2017.27 PubMed
[43] Evelyn J Cheung et al.. J Drugs Dermatol. 2016. Vitamin and Mineral Deficiencies in Patients With Telogen Effluvium: A Retrospective Cross-Sectional Study. PubMed
[44] Tee Wei Siah et al.. Int J Trichology. 2016. Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. doi:10.4103/0974-7753.188033 PubMed
[45] Kirti Deo et al.. Dermatol Res Pract. 2016. Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia and Thyroid Function. doi:10.1155/2016/6279108 PubMed
[46] Roshanak Hasheminasab Zaware et al.. Nephrourol Mon. 2016. Insomnia and Restless Leg Syndrome in Patients Undergoing Chronic Hemodialysis in Rafsanjan Ali Ibn Abitaleb Hospital. doi:10.5812/numonthly.29527 PubMed
[47] Ashutosh Singh et al.. Transfus Apher Sci. 2016. Importance of donor history of restless leg syndrome and pica to asses iron deficiency. doi:10.1016/j.transci.2015.09.002 PubMed
[48] Caroline Bittencourt et al.. Int J Dermatol. 2016. Non-invasive method distinguishes chronic telogen effluvium from mild female pattern hair loss: clinicopathological correlation. doi:10.1111/ijd.13200 PubMed
[49] Jana Zímová et al.. Acta Dermatovenerol Croat. 2016. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl. PubMed
[50] Mehmet Kolukisa et al.. Ideggyogy Sz. 2016. Restless Leg Syndrome/Willis-Ekbom disease in women with iron deficiency anemia. doi:10.18071/isz.69.0356 PubMed
[51] Andrew J Ghio. Biometals. 2016. Asthma as a disruption in iron homeostasis. doi:10.1007/s10534-016-9948-y PubMed
[52] Richard P Allen. Sleep Med Clin. 2015. Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology. doi:10.1016/j.jsmc.2015.05.022 PubMed
[53] Shashikant Malkud. J Clin Diagn Res. 2015. A Hospital-based Study to Determine Causes of Diffuse Hair Loss in Women. doi:10.7860/JCDR/2015/14089.6170 PubMed
[54] Tahir Mehmood et al.. Sleep Med. 2014. Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease). doi:10.1016/j.sleep.2014.08.012 PubMed
[55] France Woimant et al.. Handb Clin Neurol. 2014. Disorders of heavy metals. doi:10.1016/B978-0-7020-4087-0.00057-7 PubMed
[56] Behzad Einollahi et al.. Nephrourol Mon. 2014. Restless leg syndrome: a neglected diagnosis. doi:10.5812/numonthly.22009 PubMed
[57] Nicolas Perez-Mora et al.. Dermatol Ther. 2014. Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications. doi:10.1111/dth.12101 PubMed
[58] Beatriz Elizabeth Carmona Toro. J Neurosci Nurs. 2014. New treatment options for the management of restless leg syndrome. doi:10.1097/JNN.0000000000000068 PubMed
[59] Maria Rogalidou et al.. Ann Gastroenterol. 2014. Telogen effluvium as the first symptom of Crohn's disease in a child. PubMed
[60] Hatice Uce Özkol et al.. Turk J Med Sci. 2014. Is TrichoScan a new diagnostic method for diffuse hair loss? doi:10.3906/sag-1212-78 PubMed
[61] H Rasheed et al.. Skin Pharmacol Physiol. 2013. Serum ferritin and vitamin d in female hair loss: do they play a role? doi:10.1159/000346698 PubMed
[62] J Gordon Millichap et al.. Pediatrics. 2012. The diet factor in attention-deficit/hyperactivity disorder. doi:10.1542/peds.2011-2199 PubMed
[63] Stefano de Biase et al.. Expert Opin Drug Metab Toxicol. 2012. ADMET considerations for restless leg syndrome drug treatments. doi:10.1517/17425255.2012.708023 PubMed
[64] Dinesh Yadav et al.. Indian J Pediatr. 2011. Iron deficiency: beyond anemia. doi:10.1007/s12098-010-0129-7 PubMed
[65] Elise A Olsen et al.. J Am Acad Dermatol. 2010. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. doi:10.1016/j.jaad.2009.12.006 PubMed
[66] Shyam Behari Shrivastava. Indian J Dermatol Venereol Leprol. 2009. Diffuse hair loss in an adult female: approach to diagnosis and management. doi:10.4103/0378-6323.45215 PubMed
[67] Gisele Zandman-Goddard et al.. Isr Med Assoc J. 2008. Hyperferritinemia in autoimmunity. PubMed
[68] Rajiv Agarwal. Am J Nephrol. 2007. Nonhematological benefits of iron. doi:10.1159/000107927 PubMed
[69] Leonid Benjamin Trost et al.. J Am Acad Dermatol. 2006. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. doi:10.1016/j.jaad.2005.11.1104 PubMed
[70] Maria K Hordinsky. Semin Cutan Med Surg. 2006. Medical treatment of noncicatricial alopecia. doi:10.1016/j.sder.2006.01.007 PubMed
[71] Jonathan Kantor et al.. J Invest Dermatol. 2003. Decreased serum ferritin is associated with alopecia in women. doi:10.1046/j.1523-1747.2003.12540.x PubMed
[72] Jean Krieger et al.. Sleep Med Rev. 2001. Iron, brain and restless legs syndrome. doi:10.1053/smrv.2001.0156 PubMed
[73] D H Rushton. Dermatol Clin. 1993. Management of hair loss in women. PubMed

FDAに関する免責事項: これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。